The global enteral feeding formulas market size is expected to increase USD 12.51 billion by 2033 from USD 7.26 billion in 2023 with a CAGR of 5.59% between 2024 and 2033.
Key Points
- The North America enteral feeding formulas market size was estimated at USD 2.32 billion in 2023 and is expected to surpass around USD 4 billion by 2033.
- North America held the largest market share of 32% in 2023.
- By product, the standard formula segment dominated the market with the largest market share of 58% in 2023.
- By flow type, intermittent feeding flow segment has captured the largest market share of 90% in 2023.
- By stage, the adult segment has accounted for the largest share of 91% in 2023.
- By indication, the cancer care segment held a significant share of the market in 2023.
- By sales channel, the institutional segments dominated the market with the highest market share of 52% in 2023.
- By end use, the home care segment is expected to grow at the fastest CAGR of 5.92% over the forecast period.
The enteral feeding formulas market encompasses products designed to provide nutrition to patients who are unable to consume food orally. These formulas are used in healthcare settings such as hospitals and long-term care facilities, as well as for home care patients with medical conditions that necessitate tube feeding. Enteral feeding formulas contain a balanced mix of nutrients, including carbohydrates, proteins, fats, vitamins, and minerals, to support the patient’s nutritional needs.
Get a Sample: https://www.precedenceresearch.com/sample/4123
Growth Factors
The growth of the enteral feeding formulas market is primarily driven by an aging population and an increase in the prevalence of chronic diseases such as cancer, diabetes, and neurological disorders. Advances in medical technology and the development of specialized enteral feeding formulas tailored to specific medical conditions also contribute to market growth. Additionally, an increase in awareness about the benefits of enteral feeding and its role in patient recovery and quality of life further supports market expansion.
Region Insights
North America leads the enteral feeding formulas market due to its well-established healthcare infrastructure, higher healthcare expenditure, and the presence of major market players. Europe follows closely, benefiting from an aging population and a strong emphasis on research and development in the healthcare sector. The Asia-Pacific region is expected to experience significant growth due to a rising population, increasing healthcare awareness, and improved healthcare facilities.
Enteral Feeding Formulas Market Scope
| Report Coverage | Details |
| Growth Rate from 2024 to 2033 | CAGR of 5.59% |
| Global Market Size in 2023 | USD 7.26 Billion |
| Global Market Size in 2024 | USD 7.67 Billion |
| Global Market Size by 2033 | USD 12.51 Billion |
| Largest Market | North America |
| Base Year | 2023 |
| Forecast Period | 2024 to 2033 |
| Segments Covered | By Product, By Flow Type, By Stage, By Indication, By End-use, and By Sales Channel |
| Regions Covered | North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa |
Enteral Feeding Formulas Market Dynamics
Drivers
Key drivers of the enteral feeding formulas market include the rising prevalence of chronic diseases, an aging population, and advancements in medical technology. Additionally, growing awareness of the benefits of enteral feeding in managing various medical conditions and improving patients’ quality of life has led to increased adoption of these products.
Opportunities
Opportunities in the enteral feeding formulas market include the development of innovative and specialized formulas tailored to specific medical conditions or dietary restrictions. Additionally, the expansion of home care services and telehealth could create new avenues for market growth as more patients receive care outside of traditional healthcare settings. Emerging markets in regions such as Asia-Pacific and Latin America also present growth opportunities due to improving healthcare infrastructure and increasing demand for medical products.
Challenges
The enteral feeding formulas market faces challenges such as stringent regulatory requirements for product approval, which can slow down product launches and innovation. Additionally, the cost of enteral feeding products can be a barrier for some patients, especially in developing regions where healthcare resources are limited. Another challenge is the risk of complications associated with enteral feeding, such as tube displacement and infection, which can impact patient safety and outcomes.
Read Also: Dental Compressors Market Size to Touch USD 620.95 Mn by 2033
Enteral Feeding Formulas Market Recent Developments
- In September 2023, Abbott announced the plan to boost the manufacturing of various adult enteral formulas for the retail market to counteract low supply in the institutional sector.
- In February 2023, Nestlé and EraCal Therapeutics initiated a research collaboration to identify novel nutraceuticals for controlling food intake.
- In September 2022, Kate Farms introduced Adult Standard 1.4, a high-calorie medical formula now offered in chocolate. This product is designed to assist in weight gain, weight maintenance, and improved tolerance while providing a delicious taste.
- In September 2022, Kate Farms raised $75 million in a Series C funding round led by life-science investor Novo Holdings. With this, Kate Farms will be able to increase its efforts in developing plant-based clinical nutrition research, product innovation, and development into more channels.
Enteral Feeding Formulas Market Companies
- Nestlé S.A.
- Abbott Laboratories
- Mead Johnson Nutrition Company
- Fresenius Kabi AG
- Danone S.A.
- Victus Inc.
- Hormel Foods, LLC
- B. Braun Melsungen AG
- Global Health Product Inc.
- Aveanna Healthcare
- Meiji Holdings Co., Ltd.
- Nutricia
Segments Covered in the Report
By Product
- Standard Formula
- Disease-specific Formulas
- Alzheimer’s
- Nutrition Deficiency
- Cancer Care
- Diabetes
- Chronic Kidney Diseases
- Orphan Diseases
- Dysphagia
- Pain Management
- Malabsorption/GI Disorder/Diarrhea
- Others
By Flow Type
- Intermittent Feeding Flow
- Continuous Feeding Flow
By Stage
- Adults
- Pediatrics
By Indication
- Alzheimer’s
- Nutrition Deficiency
- Cancer Care
- Diabetes
- Chronic Kidney Diseases
- Orphan Diseases
- Dysphagia
- Pain Management
- Malabsorption/GI Disorder/Diarrhea
- Others
By End-use
- Hospitals
- Cardiology
- Neurology
- Critical Care (ICU)
- Oncology
- Others
- Home Care
- Long-Term Care Facilities
By Sales Channel
- Online Sales
- Retail Sales
- Institutional Sales
By Geography
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East and Africa
Contact Us:
Mr. Alex
Sales Manager
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
Web: https://www.precedenceresearch.com
Blog: https://www.expresswebwire.com/
Blog: https://www.uswebwire.com/
